share_log

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.40%)

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.40%)

bluebird bio | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.40%)
美股SEC公告 ·  11/05 02:35

牛牛AI助理已提取核心訊息

The Vanguard Group has filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in their holdings of bluebird bio, Inc. common stock. As of September 30, 2024, The Vanguard Group reported beneficial ownership of 10,474,007 shares of bluebird bio, which represents 5.40% of the company's class of common stock. This filing, made under Rule 13d-1(b), shows that The Vanguard Group has shared voting power over 87,543 shares and sole dispositive power over 10,330,825 shares, with an additional shared dispositive power over 143,182 shares. The filing indicates that The Vanguard Group's clients, including registered investment companies and other managed accounts, have the right to receive dividends or proceeds from the sale of these securities. The Vanguard Group, based in Pennsylvania, is a major investment adviser and reports no single client holding more than 5% of the interest in the reported securities.
The Vanguard Group has filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in their holdings of bluebird bio, Inc. common stock. As of September 30, 2024, The Vanguard Group reported beneficial ownership of 10,474,007 shares of bluebird bio, which represents 5.40% of the company's class of common stock. This filing, made under Rule 13d-1(b), shows that The Vanguard Group has shared voting power over 87,543 shares and sole dispositive power over 10,330,825 shares, with an additional shared dispositive power over 143,182 shares. The filing indicates that The Vanguard Group's clients, including registered investment companies and other managed accounts, have the right to receive dividends or proceeds from the sale of these securities. The Vanguard Group, based in Pennsylvania, is a major investment adviser and reports no single client holding more than 5% of the interest in the reported securities.
萬得集團已向證券交易委員會(SEC)提交了修訂後的13G表,表明其持有bluebird bio的股份發生了變化。截至2024年9月30日,萬得集團報告持有bluebird bio公司的10,474,007股股份,佔公司普通股類的5.40%。根據第13d-1(b)條規定的此項申報顯示,萬得集團對87,543股股份享有共同表決權,對10,330,825股股份享有獨立處分權,並且額外對143,182股股份享有共同處分權。此項申報顯示,萬得集團的客戶,包括註冊的投資公司和其他管理帳戶,有權獲得這些證券的分紅或出售所得。總部位於賓夕法尼亞州的萬得集團是一家主要的投資顧問,報告中未提及任何單一客戶持有所報告證券中超過5%的利益。
萬得集團已向證券交易委員會(SEC)提交了修訂後的13G表,表明其持有bluebird bio的股份發生了變化。截至2024年9月30日,萬得集團報告持有bluebird bio公司的10,474,007股股份,佔公司普通股類的5.40%。根據第13d-1(b)條規定的此項申報顯示,萬得集團對87,543股股份享有共同表決權,對10,330,825股股份享有獨立處分權,並且額外對143,182股股份享有共同處分權。此項申報顯示,萬得集團的客戶,包括註冊的投資公司和其他管理帳戶,有權獲得這些證券的分紅或出售所得。總部位於賓夕法尼亞州的萬得集團是一家主要的投資顧問,報告中未提及任何單一客戶持有所報告證券中超過5%的利益。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。